The Mayo Clinic Rare and Undiagnosed Disease Hackathon
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorMayo Clinic
About this trial
The purpose of this study is to create a Mayo Clinic biospecimen and data repository to support the evaluation of patients with rare and undiagnosed diseases through a structured, multidisciplinary diagnostic program.
Eligibility criteria
Qualifiers
Patients receiving or having received care at Mayo Clinic with rare or undiagnosed conditions; of any age (including pediatric); who can provide informed consent or have a legally authorized representative (LAR).
Patients who have undergone prior standard genetic testing that was non-diagnostic; and who are nominated by a Mayo Clinic clinician sponsor and selected by the Study Team.
Disqualifiers
Patients with a confirmed molecular or clinical diagnosis that fully explains their phenotype
Patients unable to provide consent and without a legally authorized representative (LAR)
Patients for whom sample collection cannot be coordinated
Patients enrolled in a clinical trial that precludes ancillary genomic research (evaluated on a case-by-case basis)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
50 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov